The Use of Tamoxifen as a Potential Treatment for Bipolar Disorder
- PMID: 38765942
- PMCID: PMC11079652
- DOI: 10.5152/pcp.2021.21817
The Use of Tamoxifen as a Potential Treatment for Bipolar Disorder
Abstract
Bipolar disorder (BD) is a chronic mental disease that substantially affects the patient's quality of life and causes significant morbidity and mortality. Although there are a variety of available treatments, therapeutic intervention is not beneficial in many cases and recurrence rates remain high. Recent data suggested tamoxifen, a drug with a wide range of activities, as a potential treatment for reducing manic symptoms of BD. Tamoxifen's therapeutic effect on bipolar mania has not been fully elucidated, but it is believed to biochemically operate on protein kinase C (PKC) inhibition. In this article, we review preclinical and clinical studies investigating the efficacy of tamoxifen as a potential treatment for bipolar manic patients.
Keywords: Antimanic treatment; bipolar disorder; mania; protein kinase C; tamoxifen.
2021 authors.
Conflict of interest statement
Conflict of Interest: The authors have no conflicts of interest to declare.
Similar articles
-
Tamoxifen use for the management of mania: a review of current preclinical evidence.Psychopharmacology (Berl). 2014 Feb;231(4):639-49. doi: 10.1007/s00213-013-3397-x. Epub 2014 Jan 18. Psychopharmacology (Berl). 2014. PMID: 24441937 Review.
-
Role of Protein Kinase C in Bipolar Disorder: A Review of the Current Literature.Mol Neuropsychiatry. 2017 Nov;3(2):108-124. doi: 10.1159/000480349. Epub 2017 Oct 7. Mol Neuropsychiatry. 2017. PMID: 29230399 Free PMC article. Review.
-
[Antipsychotics in bipolar disorders].Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5. Encephale. 2004. PMID: 15627046 Review. French.
-
Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen.Arch Gen Psychiatry. 2008 Mar;65(3):255-63. doi: 10.1001/archgenpsychiatry.2007.43. Arch Gen Psychiatry. 2008. PMID: 18316672 Clinical Trial.
-
Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study.Bipolar Disord. 2007 Sep;9(6):561-70. doi: 10.1111/j.1399-5618.2007.00530.x. Bipolar Disord. 2007. PMID: 17845270 Clinical Trial.
Cited by
-
The Antimanic Effect of Endoxifen in Patients with Bipolar Disorder with Renal Comorbidities: Case Series.Indian J Psychol Med. 2024 Sep 21:02537176241279547. doi: 10.1177/02537176241279547. Online ahead of print. Indian J Psychol Med. 2024. PMID: 39564329 Free PMC article.
References
-
- Murray CJ., Lopez A. D . The Global burden of disease : a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 . 1996. Boston: Harvard School of Public Health. https://apps.who.int/iris/handle/10665/41842.
LinkOut - more resources
Full Text Sources